Zonisamide for Fibromyalgia & Migraine
试验速览
- 阶段
- 4 期
- 状态
- 撤回
- 试验地点
- 2
- 主要终点
- Visual analogue score
研究概览
简要总结
Patients with fibromyalgia & migraine are randomized to receive zonisamide or placebo.
详细描述
Study was not conducted due to logistical problems
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 18 Years 至 65 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •18-65 with fibromyalgia & migraine
排除标准
- •allergy sulfa, liver or kidney disease, pregnant or not using contraception
结局指标
主要结局
Visual analogue score
时间窗: assessment measures at study enrollment (pre-treatment), and after 2, 4, and 8 weeks of treatment
assessment measures at study enrollment (pre-treatment), and after 2, 4, and 8 weeks of treatment
Tender point count
时间窗: assessment measures at study enrollment (pre-treatment), and after 2, 4, and 8 weeks of treatment
assessment measures at study enrollment (pre-treatment), and after 2, 4, and 8 weeks of treatment
Headache index
时间窗: assessment measures at study enrollment (pre-treatment), and after 2, 4, and 8 weeks of treatment
assessment measures at study enrollment (pre-treatment), and after 2, 4, and 8 weeks of treatment
次要结局
- Sleep efficiency(assessment measures at study enrollment (pre-treatment), and after 2, 4, and 8 weeks of treatment)